Ting-ting Chen

China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Nanoparticle-based drug delivery systems: A promising approach for the treatment of liver fibrosis.

Nanoparticle-based drug delivery systems: A promising approach for the treatment of liver fibrosis.

Journal: International journal of pharmaceutics: X

Published: July 07, 2025

Tryptase-like proteases: A novel perspective for fibrosis.

Tryptase-like proteases: A novel perspective for fibrosis.

Journal: Life sciences

Published: June 05, 2025

β-arrestin2 depletion attenuates autoimmune hepatitis in mice via preventing intestinal barrier disruption and inhibiting ERS mediated intestinal epithelial cells apoptosis.

β-arrestin2 depletion attenuates autoimmune hepatitis in mice via preventing intestinal barrier disruption and inhibiting ERS mediated intestinal epithelial cells apoptosis.

Journal: Biochemical pharmacology

Published: February 14, 2025

Deficiency of β-arrestin2 ameliorates MASLD in mice by promoting the activation of TAK1/AMPK signaling.

Deficiency of β-arrestin2 ameliorates MASLD in mice by promoting the activation of TAK1/AMPK signaling.

Journal: Archives of pharmacal research

Published: November 18, 2024

β-arrestin2: an emerging player and potential therapeutic target in inflammatory immune diseases.

β-arrestin2: an emerging player and potential therapeutic target in inflammatory immune diseases.

Journal: Acta pharmacologica Sinica

Published: May 07, 2024

SUMO: A new perspective to decipher fibrosis.

SUMO: A new perspective to decipher fibrosis.

Journal: Acta physiologica (Oxford, England)

Published: April 24, 2024

Insight into the regulatory mechanism of β-arrestin2 and its emerging role in diseases.

Insight into the regulatory mechanism of β-arrestin2 and its emerging role in diseases.

Journal: British journal of pharmacology

Published: January 15, 2024

Dextran sulfate sodium-induced gut microbiota dysbiosis aggravates liver injury in mice with S100-induced autoimmune hepatitis.

Dextran sulfate sodium-induced gut microbiota dysbiosis aggravates liver injury in mice with S100-induced autoimmune hepatitis.

Journal: Immunology letters

Published: April 25, 2023

β-arrestin2 deficiency ameliorates S-100-induced autoimmune hepatitis in mice by inhibiting infiltration of monocyte-derived macrophage and attenuating hepatocyte apoptosis.

β-arrestin2 deficiency ameliorates S-100-induced autoimmune hepatitis in mice by inhibiting infiltration of monocyte-derived macrophage and attenuating hepatocyte apoptosis.

Journal: Acta pharmacologica Sinica

Published: November 01, 2022

CP-25 exerts a protective effect against ConA-induced hepatitis via regulating inflammation and immune response.

CP-25 exerts a protective effect against ConA-induced hepatitis via regulating inflammation and immune response.

Journal: Frontiers in pharmacology

Published: September 11, 2022

G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases.

G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases.

Journal: Frontiers in immunology

Published: November 25, 2021

β-arrestin2 regulating β2-adrenergic receptor signaling in hepatic stellate cells contributes to hepatocellular carcinoma progression.

β-arrestin2 regulating β2-adrenergic receptor signaling in hepatic stellate cells contributes to hepatocellular carcinoma progression.

Journal: Journal of Cancer

Published: February 10, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026